# Ticagrelor in Severe Community Acquired Pneumonia

> **NCT01998399** · PHASE2 · TERMINATED · sponsor: **Gordon Bernard** · enrollment: 25 (actual)

## Conditions studied

- Community Acquired Pneumonia, Severe

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01998399
- **Lead sponsor:** Gordon Bernard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** poor enrollment, unable to meet recruitment goals
- **Last updated:** 2017-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01998399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01998399, "Ticagrelor in Severe Community Acquired Pneumonia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01998399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*